The focus of the premier issue of Genome, a new magazine that focuses on personalized medicine, is breast cancer. The top article explores how oncologists are now able to test tumors for a large number of biomarkers, enabling more targeted therapies for patients based on the molecular make up of their particular cancer.
The article featured a Jefferson patient and her physician Massimo Cristofanilli, MD, director of the Jefferson Breast Care Center. After being diagnosed with breast cancer the patient was ready to opt for a full fledge therapeutic attack on the cancer when she sought a second opinion from Dr. Cristofanilli – a national leader in the advance of personalized breast cancer care.
“I really felt that because this information was available, it wasn’t a cookie-cutter approach to cancer treatment,” the patient explained to the magazine. “It wasn’t an emotional reaction to the fear. It was based on the best science available.”
You can read the full story here.